Bullous Pemphigoid

This is a type of skin condition that causes blisters. It's usually seen in older people and isn't dangerous. Blisters form under the top layer of skin, not inside it.

Condition

What people with Bullous Pemphigoid report

Every report comes from a Lived member, sent anonymously.

Have you tried Clobetasol for Bullous Pemphigoid?

NameHow it went

About Bullous Pemphigoid

What It Is

Bullous pemphigoid is an autoimmune skin disease, meaning the immune system mistakenly attacks the body's own tissue. In this case it targets the fibers that anchor the outer layer of skin to the layer beneath. The resulting inflammation causes intense itching and large, tense blisters that feel tight and do not break easily. The blisters most often appear on the arms, legs, armpits, abdomen and groin, and less often in the mouth. It mainly affects older adults, with most people diagnosed in their 70s, and it is becoming more common as the population ages. Itching often comes first, sometimes for weeks or months, along with a rash that can look like hives or eczema. About one in five people never develop blisters at all, which is one reason the condition can be mistaken for a simple itchy rash. Bullous pemphigoid is not contagious. It matters because the itch can be relentless, open skin can become infected, and the condition carries real health risks for older people, so getting it diagnosed and controlled is worthwhile.

Causes & Risk Factors

Why the immune system starts attacking the skin is not fully understood. Age is the strongest risk factor. People with neurological conditions, including stroke, dementia, Parkinson's disease, multiple sclerosis and epilepsy, develop bullous pemphigoid more often than others, although the reason for this link is unclear. Some medicines are associated with it. The best-studied are a group of diabetes medicines called DPP-4 inhibitors, or gliptins, such as sitagliptin (Januvia), and immune checkpoint inhibitors, cancer immunotherapies such as pembrolizumab (Keytruda) and nivolumab (Opdivo). Other reported links include spironolactone, some antibiotics and some Parkinson's and dementia medicines. Even for the medicines with the clearest link, only a very small share of people who take them ever develop bullous pemphigoid, so there is no reason to avoid them in advance. Rarely, it has followed radiation therapy, ultraviolet light treatment or surgery such as a skin graft or ostomy.

How It's Diagnosed

Several blistering diseases look alike, so diagnosis usually involves a dermatologist and specialized testing. The clinician examines the skin, asks about symptoms and reviews every medicine you take, since a drug link changes management. The key test is a skin biopsy, a small sample taken during an office visit. One sample, taken from a blister, shows under the microscope that the split is beneath the outer skin layer. A second, taken from reddened or normal-looking skin next to a blister, is tested with direct immunofluorescence, a stain that lights up antibodies and immune proteins deposited in a thin line where the skin layers join. That finding is the most reliable evidence for bullous pemphigoid, and if the first test is negative but suspicion remains, the biopsy may be repeated. Blood tests can also detect antibodies against two skin proteins, called BP180 and BP230, which support the diagnosis. They are especially helpful when there are no blisters.

Treatment Options

Treatment aims to stop new blisters, heal existing ones, relieve itch and avoid harm from the medicines themselves. There is no single cure, but most people can reach remission, and the choice of treatment weighs how widespread the disease is against a person's overall health. A very strong steroid cream, usually clobetasol, is the first-line treatment and works well even for widespread blisters. Its main drawback is practical: covering large areas once or twice a day can be hard to manage without help. When that isn't feasible, oral prednisone is used. Both are tapered slowly over months once blisters stop forming. Long-term steroid pills carry real risks for older adults, including bone loss and fractures, serious infections, and higher blood sugar and blood pressure, so the aim is the lowest dose for the shortest time, with bone protection and monitoring along the way. To reduce reliance on steroids, clinicians often add a steroid-sparing medicine. Dupilumab (Dupixent), an injected biologic that blocks part of the allergic-type immune pathway involved in the disease, is FDA-approved for adults with bullous pemphigoid. In a clinical trial, adding it to steroids that were then tapered led to more remissions and fewer relapses than placebo, and it has few drug interactions, which helps people who take many medicines. Other options include doxycycline, an antibiotic used here for its anti-inflammatory effect, which is gentler than prednisone but somewhat less effective at clearing blisters; and immune-suppressing medicines such as methotrexate, mycophenolate or azathioprine, which need regular blood tests. Omalizumab (Xolair), rituximab and intravenous immunoglobulin are usually reserved for disease that has not responded to other treatments. Care of the skin itself is part of treatment. Open areas are usually cleaned and dressed daily to prevent infection, relieve pain and speed healing. If a medicine is the suspected cause, it is usually stopped and replaced in agreement with the prescriber. For cancer immunotherapy, the decision is made with the oncologist, and treatment can sometimes continue once the skin is controlled.

What to Expect

Bullous pemphigoid usually lasts months to years rather than weeks. With treatment, most people see new blisters stop within a few weeks, and about half reach complete remission within around two years. Many stay on some treatment for six months to five years before it can be stopped; some need longer, and the disease can return after remission. Healed blisters do not usually scar, though temporary dark or light patches can remain. Daily life during active disease often revolves around itch, skin care and dressings. Applying creams over large areas, managing dressings and keeping track of appointments can be demanding, especially for someone frail or living alone, so help from family, home nursing or a wound care service can make a real difference. Regular follow-up lets the dermatologist adjust doses, watch for side effects such as bone loss or infection, and coordinate with other doctors. The outlook depends heavily on overall health. Because the condition mostly affects older people who often have other illnesses, and because both the disease and long-term steroids add strain, people with bullous pemphigoid have a higher risk of death in the first year than others their age. This is a main reason clinicians aim to control the skin quickly while keeping steroid exposure low.

When to Seek Help

See a clinician, ideally a dermatologist, if you have persistent itching with a rash or blisters that do not clear, particularly if you are older or recently started a new medicine. Contact your care team if blisters or itching come back after treatment, or if a medicine causes side effects you are worried about. Get medical care the same day if blisters are leaking and opening up, if large areas of skin are raw, or if open areas look infected, because widespread open skin can lead to serious infection that may need hospital care.

Questions to Ask Your Doctor

  1. 1.Does my biopsy confirm bullous pemphigoid, or could this be a different blistering condition?
  2. 2.Could any of my current medicines be contributing, and is it safe to switch?
  3. 3.Is a steroid cream practical for me, or would tablets or a medicine like dupilumab suit my situation better?
  4. 4.If I take steroids for months, what will we do to protect my bones and watch for infection?
  5. 5.How should my blisters and open skin be cared for at home, and can I get help with dressings?

Last reviewed • Oct 2026

Educational content, not medical advice.